$59.5 Million is the total value of Healthcare Value Capital, LLC's 26 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | $3,810,000 | -13.9% | 50,000 | 0.0% | 6.41% | -50.8% | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $3,789,000 | -19.4% | 100,000 | 0.0% | 6.37% | -53.9% | |
| GILD | New | GILEAD SCIENCES INCcall | $3,738,000 | – | 50,000 | +100.0% | 6.29% | – |
| GILD | Sell | GILEAD SCIENCES INC | $3,738,000 | -17.8% | 50,000 | -28.6% | 6.29% | -53.1% |
| SPXU | New | PROSHARES TRultrapro short s | $3,618,000 | – | 150,000 | +100.0% | 6.08% | – |
| CAH | Buy | CARDINAL HEALTH INC | $3,596,000 | +103.2% | 75,000 | +114.3% | 6.05% | +16.1% |
| MCK | Buy | MCKESSON CORP | $3,382,000 | +144.5% | 25,000 | +150.0% | 5.69% | +39.7% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $3,351,000 | – | 75,000 | +100.0% | 5.64% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $3,160,000 | – | 25,000 | +100.0% | 5.32% | – |
| SPXL | New | DIREXION SHS ETF TRcall | $3,126,000 | – | 120,000 | +100.0% | 5.26% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $2,992,000 | – | 30,000 | +100.0% | 5.03% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $2,694,000 | – | 30,000 | +100.0% | 4.53% | – |
| ABC | Buy | AMERISOURCEBERGEN CORP | $2,655,000 | +56.2% | 30,000 | +50.0% | 4.47% | -10.8% |
| TYME | TYME TECHNOLOGIES INC | $2,393,000 | -21.4% | 2,175,000 | 0.0% | 4.02% | -55.1% | |
| MNLO | New | MENLO THERAPEUTICS INC | $2,278,000 | – | 850,000 | +100.0% | 3.83% | – |
| SPXU | New | PROSHARES TRcall | $1,809,000 | – | 75,000 | +100.0% | 3.04% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $1,590,000 | +1.7% | 250,000 | +66.7% | 2.67% | -41.9% |
| CVS | Sell | CVS HEALTH CORP | $1,483,000 | -60.1% | 25,000 | -50.0% | 2.49% | -77.2% |
| ATRS | Buy | ANTARES PHARMA INC | $1,180,000 | -16.3% | 500,000 | +66.7% | 1.98% | -52.2% |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $1,144,000 | – | 25,000 | +100.0% | 1.92% | – |
| BIS | New | PROSHARES TRcall | $1,058,000 | – | 75,000 | +100.0% | 1.78% | – |
| AMRN | New | AMARIN CORP PLCcall | $800,000 | – | 200,000 | +100.0% | 1.35% | – |
| CLVS | CLOVIS ONCOLOGY INCcall | $636,000 | -39.0% | 100,000 | 0.0% | 1.07% | -65.1% | |
| ADMS | ADAMAS PHARMACEUTICALS INCcall | $578,000 | -23.7% | 200,000 | 0.0% | 0.97% | -56.4% | |
| VKTX | New | VIKING THERAPEUTICS INCcall | $468,000 | – | 100,000 | +100.0% | 0.79% | – |
| GNLN | Buy | GREENLANE HLDGS INCcl a | $387,000 | -32.1% | 225,000 | +28.6% | 0.65% | -61.2% |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTDcall | $0 | – | -50,000 | -100.0% | -0.49% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -350,000 | -100.0% | -3.43% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -5.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.